Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001348362-25-000017
Filing Date
2025-10-01
Accepted
2025-10-01 14:46:31
Documents
1
Effectiveness Date
2025-10-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11536
  Complete submission text file 0001348362-25-000017.txt   12905
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: D | Act: 33 | File No.: 021-559470 | Film No.: 251364107
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)